Identification of tumor biomarkers for pathological complete response to neoadjuvant treatment in locally advanced breast cancer

被引：0
|
作者：
Prarthana Gopinath
Sridevi Veluswami
Gopal Gopisetty
Shirley Sundersingh
Swaminathan Rajaraman
Rajkumar Thangarajan
机构：
[1] Cancer Institute WIA,Department of Molecular Oncology
[2] Cancer Institute WIA,Department of Surgical Oncology
[3] Cancer Institute WIA,Department of Oncopatholology
[4] Cancer Institute WIA,Department of Epidemiology, Biostatistics and Cancer Registry
来源：
Breast Cancer Research and Treatment | 2022年 / 194卷
关键词：
Predictive marker; Locally advanced breast cancer; Thrombospondin-1; Tenascin-C; Decorin; High-mobility group box 1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：207 / 220
页数：13
相关论文
共 50 条
  • [31] CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy
    Furlan Matos Alves, Wilson Eduardo
    Bonatelli, Murilo
    Dufloth, Rozany
    Kerr, Ligia Maria
    Angotti Carrara, Guilherme Freire
    Alves da Costa, Ricardo Filipe
    Scapulatempo-Neto, Cristovam
    Tiezzi, Daniel
    da Costa Vieira, Rene Aloisio
    Pinheiro, Celine
    BMC CANCER, 2019, 19 (01)
  • [32] Pharmacogenetics of response to neoadjuvant paclitaxel treatment for locally advanced breast cancer
    Perez-Ortiz, Andric C.
    Ramirez, Israel
    Cruz-Lopez, Juan C.
    Villarreal-Garza, Cynthia
    Luna-Angulo, Alexandra
    Lira-Romero, Esmeralda
    Jimenez-Chaidez, Salvador
    Diaz-Chavez, Jose
    Matus-Santos, Juan A.
    Sanchez-Chapul, Laura
    Mendoza-Lorenzo, Patricia
    Estrada-Mena, Francisco J.
    ONCOTARGET, 2017, 8 (63) : 106454 - 106467
  • [33] IMMUNOHISTOCHEMICAL PREDICTORS OF THE CLINICAL AND PATHOLOGICAL RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED BREAST CANCER
    Rodionova, M.
    Ryabchikov, D.
    Portnoy, S.
    Vorotnikov, I.
    Chkhikvadze, N.
    ANNALS OF ONCOLOGY, 2012, 23 : 130 - 131
  • [34] Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer
    Fernández-Sánchez, M
    Gamboa-Dominguez, A
    Uribe, N
    García-Ulloa, AC
    Flores-Estrada, D
    Candelaria, M
    Arrieta, O
    MEDICAL ONCOLOGY, 2006, 23 (02) : 171 - 183
  • [35] Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer
    Mónica Fernández-Sánchez
    Armando Gamboa-Dominguez
    Norma Uribe
    Ana Cristina García-Ulloa
    Diana Flores-Estrada
    Myrna Candelaria
    Oscar Arrieta
    Medical Oncology, 2006, 23 : 171 - 183
  • [36] Tumor Biology Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients Presenting with Locally Advanced Breast Cancer
    Gentile, L.
    Plitas, G.
    Zabor, E.
    Stempel, M.
    Morrow, M.
    Barrio, A. V.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S67 - S67
  • [37] Tumor Biology Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients Presenting with Locally Advanced Breast Cancer
    Gentile, Lori F.
    Plitas, George
    Zabor, Emily C.
    Stempel, Michelle
    Morrow, Monica
    Barrio, Andrea V.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (13) : 3896 - 3902
  • [38] Tumor Biology Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients Presenting with Locally Advanced Breast Cancer
    Lori F. Gentile
    George Plitas
    Emily C. Zabor
    Michelle Stempel
    Monica Morrow
    Andrea V. Barrio
    Annals of Surgical Oncology, 2017, 24 : 3896 - 3902
  • [39] Quantitative DCE-MRI for prediction of pathological complete response following neoadjuvant treatment for locally advanced breast cancer: the impact of breast cancer subtypes on the diagnostic accuracy
    Drisis, Stylianos
    Metens, Thierry
    Ignatiadis, Michael
    Stathopoulos, Konstantinos
    Chao, Shih-Li
    Lemort, Marc
    EUROPEAN RADIOLOGY, 2016, 26 (05) : 1474 - 1484
  • [40] Quantitative DCE-MRI for prediction of pathological complete response following neoadjuvant treatment for locally advanced breast cancer: the impact of breast cancer subtypes on the diagnostic accuracy
    Stylianos Drisis
    Thierry Metens
    Michael Ignatiadis
    Konstantinos Stathopoulos
    Shih-Li Chao
    Marc Lemort
    European Radiology, 2016, 26 : 1474 - 1484
12345